Alligator Bioscience awarded Orphan Drug Designation for mitazalimab
Lund-based Alligator Bioscience continues to increase the value of its lead asset mitazalimab. The company recently announced receiving Orphan Drug Designation for the CD40...
Dicot heading towards summer with strengthened team and finances
In August, Dicot is expected to take its biggest step as a development company with the planned initiation of a phase I clinical trial...
Flerie Invest’s Carl-Johan Spak elected to Lipum’s Board
At Lipum's Annual General Meeting on May 10, Carl-Johan Spak was elected as a new board member of Lipum. Carl-Johan is a senior advisor...
Respiratorius continues its search for a partner
After good results in the PK study with VAL001, only one activity remains for Respiratorius, to sign an agreement. In a quarter with a...
Neola Medical kicks off the market preparations
Neola Medical is in full swing setting the stage for its medical device. While generating interest among neonatal intensive care units around Europe, technical...
Tripled sales for Invent Medic
It hardly came as a surprise that Invent Medic showed good growth in the first quarter of 2023. A whooping 300 per cent increase...
Highlights from SynAct Pharma’s Capital Markets Day
On May 5, SynAct Pharma held a Capital Markets Day in Stockholm featuring presentations from the management team, as well as Key Opinion Leaders...
Arcede approaching dosing in tox study
When reporting on first quarter of 2023, Arcede Pharma have an eventful period to look back on. Now all eyes are on the final...
Aqilion – Disrupting the Vicious Cycle of Chronic Inflammation
Chronic inflammation is an underlying cause of many diseases and represents an immense societal burden. Researchers continue to struggle to solve the riddle behind...
Zyneyro’s CEO on the collaboration with CombiGene
At the beginning of the year, CombiGene and Zyneyro entered into a collaboration for the development of new treatments for severe chronic pain conditions....
